Elizabeth “Betsy” Folk, MBA, retired as Executive Vice President and Chief Operating Officer on Jan. 9, 2026, following a successful leadership career at HJF spanning more than 30 years.

A large military-led clinical trial has found that an oral supplement made from hyperimmune bovine colostrum (HBC) - the active ingredient in the commercially available product Travelan® - did not...

Following her outstanding tenure as Vice President, Strategic Initiatives, Sheara Fewell, Ph.D., has been promoted to Senior Vice President, Strategic Initiatives.

HJF gathered over 200 of its scientistsfor its inaugural HJF Research Day on November 19, 2025.

HJF recently celebrated the 2025 honorees of the Heroes of Military Medicine San Antonio Awards.

MONSTROUS new web-based platform is bringing artificial intelligence (AI) into early-stage countermeasure discovery and drug safety research.

HJF receives funding through a grant from Wounded Warrior Project® (WWP) for the 7 East Brain Injury Medicine/Neuropsychiatry Program at WRNMMC

An HJF team from the Center for the Study of Traumatic Stress met with members of the Joint Mortuary Affairs Center

A Practical Guide to Prolonged Casualty Care was recently published jointly by the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) and the Uniformed Services University (USU...

HJF once again selected to receive gift of $500,000 from retired Admiral William McRaven as part of 2024 Bezos Courage and Civility Award.

HJF recently announced new leadership positions for two growing business segments.

First year of HJF supported BLAST EMFASIS study investigates how subconcussive blast exposure affects brain function differently in males vs. females.

HJF and MDC join forces to revolutionize medical technology development and commercialization, benefiting military and civilian health care sectors.

HJF is pleased to announce the 2025 honorees receiving the HJF Heroes of Military Medicine Awards

William “Buddy” B. Kinner has been promoted to Senior Vice President, General Counsel, and Secretary following the retirement of Catherine Clark.